Therapeutic DNA vaccine against Trypanosoma cruzi infection in dogs: A pilot clinical trial

Annals of the New York Academy of Sciences

Volumn 1149, Issue , 2008, Pages 343-346

  Quijano Hernandez, Israel Alejandro ^a   Bolio González, Manuel Emilio ^a   Rodríguez Buenfil, Jorge Carlos ^a   Ramirez Sierra, María Jesus ^a   Dumonteil, Eric ^a  

^a UNIVERSIDAD AUTÓNOMA DE YUCATÁN   (Mexico)

Author keywords

Chagas' disease; DNA vaccine; Dog; Trypanosoma cruzi

Indexed keywords

ALUMINUM PHOSPHATE; DNA VACCINE; IMMUNOGLOBULIN G; PLASMID DNA; TRYPANOSOMA CRUZI VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY RESPONSE; BLOOD SMEAR; CELL DENSITY; CHAGAS DISEASE; CONFERENCE PAPER; CONTROLLED STUDY; DISEASE COURSE; DOG DISEASE; DRUG EFFICACY; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPERIMENTAL INFECTION; HEART; HISTOPATHOLOGY; IMMUNOTHERAPY; INFLAMMATORY CELL; NONHUMAN; PARASITEMIA; SCORING SYSTEM; TREATMENT RESPONSE; TRYPANOSOMA CRUZI; TRYPANOSOMIASIS; VACCINATION;

CANIS FAMILIARIS; MUS; TRYPANOSOMA CRUZI;

EID: 57849095162     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1428.098     Document Type: Conference Paper

References (13)

1. Andrade, Z.A. 1999. Immunopathology of Chagas disease. Mem. Inst. Oswaldo Cruz 94 (Suppl 1 71 80.
2. Gurtler, R.E. et al. 2007. Domestic dogs and cats as sources of Trypanosoma cruzi infection in rural northwestern Argentina. Parasitology 134 : 69 82.
3. de Lana, M. et al. 1992. Experimental Chagas' disease in dogs. Mem. Inst. Oswaldo Cruz 87 : 59 71.
4. Urbina, J.A. & R. Docampo. 2003. Specific chemotherapy of Chagas disease: controversies and advances. Trends Parasitol. 19 : 495 501.
5. Dumonteil, E. 2007. DNA vaccines against protozoan parasites: opportunities and challenges. J. Biomed. Biotechnol. 2007 : Article ID 90520 doi :. 11 pages.
6. Dumonteil, E. et al. 2004. Immunotherapy of Trypanosoma cruzi infection with DNA vaccines in mice. Infect. Immun. 72 : 46 53.
7. Zapata-Estrella, H. et al. 2006. Control of Trypanosoma cruzi infection and changes in T cell populations induced by a therapeutic DNA vaccine in mice. Immunol. Lett. 103 : 186 191.
8. Autran, B. et al. 2004. Therapeutic vaccines for chronic infections. Science 305 : 205 208.
9. Wizel, B. et al. 1998. Vaccination with trypomastigote surface antigen 1-encoding plasmid DNA confers protection against lethal Trypanosoma cruzi infection. Infect. Immun. 66 : 5073 5081.
10. Ouaissi, A. et al. 1992. Cloning and sequencing of a 24-kDa Trypanosoma cruzi specific antigen released in association with membrane vesicles and defined by a monoclonal antibody. Biol. Cell 75 : 11 17.
11. Sanchez-Burgos, G. et al. 2007. Comparative efficacy of DNA vaccines encoding various Trypanosoma cruzi antigens. FEMS Microbiol. Med. Immunol. 50 : 333 341.
12. Rosado-Vallado, M. et al. 2005. Aluminium phosphate potentiates DNA vaccines against Leishmania mexicana. Vaccine 23 : 5372 5379.
13. Handman, E. et al. 2000. Therapy of murine cutaneous leishmaniasis by DNA vaccination. Vaccine 18 : 3011 3017.